Digestive Health Institute, Children's Hospital Colorado, Gastrointestinal Eosinophilic Diseases Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, Colorado, USA.
Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Am J Gastroenterol. 2024 Jul 1;119(7):1298-1308. doi: 10.14309/ajg.0000000000002644. Epub 2024 Jan 4.
INTRODUCTION: Eosinophilic gastritis (EoG) and duodenitis (EoD) are rare conditions that are poorly understood. Our aim was to describe the natural history of children with varying degrees of gastric or duodenal eosinophilia with respect to disease complications and histologic and endoscopic longitudinal trajectories. METHODS: The electronic medical record at a tertiary children's hospital was queried to identify patients with EoG, EoD, or EoG + EoD who were cared for between January 2010 and 2022. Multiple logistic regression was performed to explore associations between baseline features and persistence/recurrence of eosinophilia or complications remote from diagnosis. RESULTS: We identified 151 patients: 92 with EoG, 24 with EoD, 12 with EoG + EoD, and 23 with tissue eosinophilia but did not meet histologic criteria for EoG or EoD (low grade). The average age at diagnosis was 10.6 years, and average follow-up was 5.8 years. Twenty-five percent of patients with EoG or EoD had persistence/recurrence of eosinophilia; this was associated with increases in the EoG Endoscopic Reference Score (adjusted odds ratio [aOR] 1.34, confidence interval [CI] 1.03-1.74) on diagnostic endoscopy. Eighteen percent suffered from disease complications, and development of late complications was associated with presenting with a complication (aOR 9.63, CI 1.09-85.20), severity of duodenal endoscopic abnormalities (aOR 8.74, CI 1.67-45.60), and increases in the EoG Endoscopic Reference Score (aOR 1.70, CI 1.11-2.63). DISCUSSION: Patients with gastric and duodenal eosinophilia should be followed closely to monitor for recurrence and complications, especially those presenting with endoscopic abnormalities or complications.
简介:嗜酸性粒细胞性胃炎(EoG)和十二指肠炎(EoD)是两种罕见的疾病,目前人们对其了解甚少。本研究旨在描述不同程度胃或十二指肠嗜酸性粒细胞增多症患者的自然病史,包括疾病并发症、组织学和内镜纵向轨迹。
方法:通过检索一家三级儿童医院的电子病历,确定了 2010 年 1 月至 2022 年期间患有 EoG、EoD 或 EoG+EoD 的患者。采用多因素逻辑回归分析探讨了基线特征与嗜酸性粒细胞持续存在/复发或诊断后远处并发症之间的关系。
结果:我们共纳入 151 例患者:92 例 EoG、24 例 EoD、12 例 EoG+EoD、23 例组织学嗜酸性粒细胞增多但不符合 EoG 或 EoD(低级别)的组织学标准。诊断时的平均年龄为 10.6 岁,平均随访时间为 5.8 年。25%的 EoG 或 EoD 患者存在嗜酸性粒细胞持续存在/复发,这与诊断内镜时 EoG 内镜参考评分的增加有关(调整后的优势比 [aOR] 1.34,95%置信区间 [CI] 1.03-1.74)。18%的患者发生了疾病并发症,晚期并发症的发生与初诊时即存在并发症(aOR 9.63,95%CI 1.09-85.20)、十二指肠内镜异常严重程度(aOR 8.74,95%CI 1.67-45.60)和 EoG 内镜参考评分的增加(aOR 1.70,95%CI 1.11-2.63)相关。
讨论:胃和十二指肠嗜酸性粒细胞增多症患者应密切随访,以监测复发和并发症,尤其是那些存在内镜异常或并发症的患者。
Am J Gastroenterol. 2024-7-1
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2011-12-7
Cochrane Database Syst Rev. 2023-10-23
Cochrane Database Syst Rev. 2020-9-14
Cochrane Database Syst Rev. 2016-8-22
Cochrane Database Syst Rev. 2017-3-23
Gastroenterol Hepatol (N Y). 2025-8